TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
JANX

Janux Therapeutics Inc

Healthcare · Biotechnology

16.30$ -2.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Janux Therapeutics Inc (JANX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,008 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet JANX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
387 380 689 691 695 1,062 1,051 1,032 1,025 1,008 1,028 1,008
355 349 659 662 666 1,034 1,023 1,006 998 976 1,002 983
17 19 213 15 27 431 74 52 48 52 52 28
350 344 652 646 658 1,025 1,014 996 989 967 956 971
1.7 2.2 4.4 12 4.5 5.4 5.6 5.7 6.3 6.4 42 6.3
-1.7 -2.2 – 0.0 – – – – – – – –
38 36 33 34 39 39 38 42 48 51 87 80
14 13 11 12 17 17 18 21 28 25 59 60
1.5 1.5 1.6 1.6 1.7 1.7 1.8 1.9 2.3 2.4 2.5 2.6
2.5 2.4 2.3 1.3 2.5 4.0 2.4 3.5 3.4 5.0 3.4 3.0
349 344 656 658 656 1,023 1,012 991 977 957 942 928
-157 -169 -184 -189 -218 -238 -261 -295 -319 -351 -376 -398
46 47 49 54 55 57 62 62 62 62 63 63

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?